Dr. Bob Argiropoulos is currently the laboratory head of the Constitutional Cytogenetics laboratory at the Alberta Children's Hospital and of the Cancer Cytogenetics Laboratory at the Diagnostic and Scientific Center. In his spare time, Bob can be found climbing ice and rock in the Rocky mountains.
Dr. Nathanael Baile is an associate professor of pathology in the Division of Hematopathology at the University of Pittsburgh and UPMC, where he directs the hematopathology fellowship. Prior to joining UPMC, he was an assistant professor at the University of Michigan, where he also directed the molecular genetic pathology fellowship program. Dr. Bailey trained in molecular genetic pathology at the University of Michigan after completing a hematopathology fellowship and anatomic and clinical pathology residency training at West Virginia University. Dr. Bailey has coauthored numerous manuscripts, review articles, and book chapters on the molecular basis of hematolymphoid neoplasms. Dr. Bailey is especially interested in pathology education and has been awarded for his resident teaching and is the current chair of the Training and Education committee of the Association for Molecular Pathology. He has spoken at several national meetings and is active in many professional societies.
Adrian Box, MD, PhD, FRCPC, DABP is a Anatomical and Molecular Pathologist at the Foothills Medical Center. He completed his BSc in Biochemistry at the University of Calgary in 1998, a MD/Ph.D degree with specialization in Cancer Biology in 2008, and residency training in anatomical pathology in 2015. He completed fellowship training in Molecular Genetic Pathology at Emory University in 2016 and worked as an Anatomical and Molecular pathologist at the University of Alberta Hospital in Edmonton until joining the Foothills Medical Center AP department in 2018. He is a fellow of the Royal College of Physicians of Canada and a diplomate of the American Board of Pathology with certification in Anatomical Pathology and subspecialty certification in Molecular Genetic Pathology. Dr. Box is the current Medical Lead for Alberta Precision Laboratories, Molecular Pathology Lab South and has particular interest in laboratory assay design for tissue optimization/quality assurance.
Dr. Dennis Bulman is the Medical Scientific Director of Genetics and Genomics. He is a Clinical Professor in the Departments of Medical Genetics, as well as the Department of Pathology and Lab Medicine and is a member of the Alberta Children's Hospital Research Institute. He is board certified in Clinical Molecular Genetics from both the CCMG and ACMG. He has extensive training in human molecular genetics and has been involved in the discovery of more than 40 novel disease genes. Currently he is working towards establishing an undiagnosed disease research program as a means to eliminating the diagnostic odyssey.
Dr. Soufiane El Hallani is a Molecular & Anatomical Pathologist and an Assistant Professor at the University of Alberta. His learning journey started in Marrakesh (Morocco) where he completed his MD degree. A life-long passionate of Genetics, he completed a Master in Human Genetics and a PhD in Oncology and Cancer Biology from the University of Paris South (France). He then moved to North-America to pursue a post-doctoral research fellowship at the BCCA (Vancouver, British Columbia) working on the development of image analysis apps in digital pathology. Motivated by the translation of research knowledge to the clinical side, he first completed a residency program in Anatomical Pathology at the University of Ottawa (Ottawa, Ontario), then pursued an advanced training by completing the Molecular & Genetic Pathology fellowship at the University of Pittsburgh Medical Centre (Pennsylvania, USA) and the Gynecologic Pathology fellowship at Stanford University Medical Center (California, USA).
Dr. Iyare Izevbaye obtained his medical degree and MSC in Biochemistry at the University of Ibadan, Nigeria, after which he completed a PhD in Molecular Biology in University of Alabama, USA. He did residency training in Anatomic/Clinical Pathology in the University of Buffalo, New York. He had further fellowship training in oncologic surgical pathology at the Roswell Park Cancer Institute and molecular genetic pathology at the Mayo Clinic, Rochester. Currently an Associate Professor at the Department of Lab Medicine and Pathology, Univeristy of Alberta and molecular pathologist and scientific lead at the APL molecular pathology Lab, North Edmonton.
Dr. Faisal M. Khan is an Associate Professor Clinical Director of Hematology Translational Lab at University of Calgary. In his clinical role, Dr. Khan works as as an Associate Clinical Director of Histocompatibility and Immunogenetic Lab (HIL) and as Scientific Lead of Molecular Pathology Program in Alberta Precision Labs. Dr. Khan obtained his PhD in Human Molecular Genetics in India in 2006. He completed his postdoctoral training and clinical fellowship at the University of Calgary. Dr. Khan is a certified Diplomat of American Board of Histocompatibility and Immunogenetics (ABHI). Dr. Khan has more than 21 years of experience in Transplant Immunology, Cancer Genomics and Histocompatibility and Immunogenetics. Based on his research, Dr. Khan has published >90 research articles in scientific journals like Science, Blood, and Blood Advances. His research has been recognized by several awards including American Society of Hematology (ASH) Achievement Awards in 2013, 2015 and 2018.
Megan S. Lim, MD, PhD is the Director of the Division of Hematopathology, Hospital of the University of Pennsylvania, and Professor within the Department of Pathology and Laboratory Medicine, Director of the Hematopathology Fellowship Program, and the Director of the Lymphoma Biology Program at the Abramson Cancer Center. Dr. Lim is certified by the American Board of Pathology in Anatomic Pathology, with subspecialty certification in Hematopathology and Molecular Genetic Pathology. She has held numerous leadership positions and served on training and education committees for the Association of Molecular Pathology and the United States Academy of Pathology. She has served as a member of the Board of Directors for the United States Academy of Pathology. She has contributed to the scientific missions of the Children's Oncology Group (Vice-Chair of the Non-Hodgkin Lymphoma Disease Committee, 2010-2021) and participates in integrated translational research in pediatric lymphoma.
Dr. Remegio Maglantay received his MD from the University of the Philippines and completed Anatomic and Clinical Pathology residency training at the State University of New York Health Sciences Center in Brooklyn. He subsequently completed subspecialty fellowships in Cytopathology at the Massachusetts General Hospital/Harvard Medical School and Molecular Genetic Pathology at the University of Pittsburgh Medical Center. He is a fellow of the College of American Pathologists with board certification in Anatomic and Clinical Pathology, Cytopathology, and Molecular Genetic Pathology. Dr. Maglantay currently works as a surgical pathologist, cytopathologist, and molecular pathologist at APL and splits his time between University of Alberta Hospital and Royal Alexandra Hospital. He also participates actively in resident teaching and mentorship. His research interests are primarily focused on the application of molecular diagnostics in cytopathology.
Etienne Mahe is an hematological pathologist based in Calgary, Alberta, Canada. Dr. Mahe has specialist certificates from the Royal College of Physicians & Surgeons of Canada in both Anatomical and Hematological pathology, and is a diplomate of the American Board of Pathology. Dr. Mahe completed his medical degree and residency at McMaster University, as well as a research based master's degree in pathology at the University of Toronto. Dr. Mahe the Alberta Precision Laboratory Team Lead for Lymphoma & Myeloma molecular pathology, and has a significant interest in next-generation sequencing. Dr. Mahe's primary research interests relate to T- and B-cell clonality technologies and assay development. Dr. Mahe is actively involved in medical education, including the coordination of undergraduate teaching. Dr. Mahe is the secretary-treasurer of the Alberta Section of Laboratory Medicine and is a member of the College of American Pathologists' Hematology & HEMEPATH Committees.
Dr. Cheryl Mather is an anatomic and molecular pathologist with a focus in GI and liver pathology. As part of her role as an anatomic pathologist for Alberta Precision Laboratories, she recently worked to introduce universal screening for Lynch syndrome for all colorectal cancers in Alberta. When not working in the lab, Cheryl is the ringleader of her own circus of six children.
Jonathan Said is Professor of Pathology and Chief of Hematopathology at UCLA Medical Center and the David Geffen School of Medicine. I addition to over 400 peer reviewed articles he is the authors of chapters in the WHO Classification of Haematopoietic and Lymphoid Tissues, as well as chapters on hematopathology in the newly published WHO Thoracic Tumours and soon to be published Pediatric Tumours books.
Dr. Doug Stewart obtained his medical degree from the University of Alberta in 1987, completed Internal Medicine and Medical Oncology Residencies at the University of Ottawa, and then a Fellowship in Bone Marrow Transplantation (BMT) and Lymphoma management at the University of Nebraska. Since July 1994, Dr. Stewart has been practicing Medical Oncology in Calgary where he is a member of the BMT Program, Hematology and Breast Tumor Groups. His clinical research activities involving lymphoma and BMT have resulted in over 170 peer-reviewed publications, and in 2019 he attained the academic rank of Professor Emeritus in the Department of Oncology at the University of Calgary. Dr. Stewart's leadership positions include terms as Medical Oncology Residency Training Program Director, RCPSC Medical Oncology Examination Board Chair, Provincial Hematology Tumor Team Leader, Hematology Division Chief, and currently the Senior Medical Director of the Cancer Strategic Clinical Network, AHS.
Dr. Sherry Taylor received her PhD in 1990 identifying mutations in the F8 and F9 genes. She undertook a fellowship with Dr. James Gusella at Harvard Medical School and was a member of the team which cloned the gene for Huntington disease. Returning to Canada she obtained her CCMG and pursued molecular diagnostics. Moving to Edmonton in 2012 she is the Co-Head of the Molecular Genetics Laboratory and the North Sector Medical Lead for Genetics and Genomics, Alberta Precision Laboratories. She is an Associate Professor in the Department of Medical Genetics and cross appointed to Laboratory Medicine and Pathology at the University of Alberta.
Dr. Taylor has had a leading role in undergraduate medical education at Queen's, Dalhousie and the University of Alberta. Her research has focused on epigenetic risk factors in colorectal cancer and as a collaborator on the Genome Canada Translational Implementation of Genomics for Rare Disease program in Alberta.
Dr. Taylor has had a leading role in undergraduate medical education at Queen's, Dalhousie and the University of Alberta. Her research has focused on epigenetic risk factors in colorectal cancer and as a collaborator on the Genome Canada Translational Implementation of Genomics for Rare Disease program in Alberta.
Dr Gareth Turner - I am a Consultant and Senior Clinical Lecturer in Haematopathology at the Department of Cellular Pathology and Radcliffe Department of Medicine, Oxford Radcliffe Universities NHS Trust and Oxford University.
I have worked as a clinical histopathologist in a variety of NHS and University roles for 30 years. I trained in Cambridge and qualified from Oxford Medical School then gained a DPhil in the Pathology of Malaria the WIMM in Oxford, working with our units in Viet Nam and Thailand under Prof Sir Nick White. I trained in Pathology with a Wellcome Trust Fellowship under Prof Kevin Gatter, researching malaria pathogenesis, and collaborating with groups in Thailand, Vietnam and Africa on projects involving malaria, dengue fever, melioidsos, rickettsial infections and pneumonia. More recently I was the Head of Pathology at the Oxford unit in Mahidol University Thailand, and involved in projects aiding education of pathologists in SE Asia.
I have worked as a clinical histopathologist in a variety of NHS and University roles for 30 years. I trained in Cambridge and qualified from Oxford Medical School then gained a DPhil in the Pathology of Malaria the WIMM in Oxford, working with our units in Viet Nam and Thailand under Prof Sir Nick White. I trained in Pathology with a Wellcome Trust Fellowship under Prof Kevin Gatter, researching malaria pathogenesis, and collaborating with groups in Thailand, Vietnam and Africa on projects involving malaria, dengue fever, melioidsos, rickettsial infections and pneumonia. More recently I was the Head of Pathology at the Oxford unit in Mahidol University Thailand, and involved in projects aiding education of pathologists in SE Asia.